GRI Bio, Inc.
GRI
$2.31
$0.062.67%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -36.50% | -58.29% | -28.53% | -61.42% | 2.79% |
| Total Depreciation and Amortization | 0.00% | 0.00% | 0.00% | 0.00% | 102.63% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 61.22% | 917.02% | 150.48% | 371.43% | 144.14% |
| Change in Net Operating Assets | -288.12% | 392.27% | -253.99% | 394.54% | 97.04% |
| Cash from Operations | -48.62% | -1.98% | -47.87% | 21.20% | 64.05% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 236.56% | 57.59% | 19.78% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -786.46% | -2.19% | -67.68% | 99.01% | -102.47% |
| Cash from Financing | 213.37% | 88.50% | 13.72% | -100.25% | -41.21% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,380.14% | 33.60% | -18.61% | -176.52% | 116.79% |